Eric Warren, Chief Commercial Officer: Esperion Therapeutics ESPR Sell · Filed 24/12/18

Trade details

Type: Insider sale
Amount: $5,428.62
Shares · price: 2,234 sh · $2.43 a share
Held after: 160,121 sh
Stock: Esperion Therapeutics ESPR
Person: Eric WarrenChief Commercial Officer
Trade date: 24/12/17
Filed: 24/12/18
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Esperion Therapeutics trades, last 26 weeks

What else happened in Esperion Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/17~25/01/16

Eric Warren's recent trades

Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$209.1K
7,438 sh
$209.1K
Filed 09/21
Traded 09/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$193.2K
7,437 sh
$193.2K
Filed 08/21
Traded 08/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$199.9K
7,438 sh
$199.9K
Filed 07/21
Traded 07/21
Eric WarrenChief Commercial Officer
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/30
Traded 06/26
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/29
Traded 06/26

Eric Warren, Chief Officer — sold $5,429 of Esperion Therapeutics ESPR · 1.4% of holdings | Whalegun